<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Talbot LJ</submitter><funding>Rally Foundation</funding><funding>Assisi Foundation of Memphis</funding><funding>St. Jude Children&amp;apos;s Research Hospital</funding><funding>NCI NIH HHS</funding><pagination>691741</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8239305</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>The outcome for metastatic pediatric osteosarcoma (OS) remains poor. Thus, there is an urgent need to develop novel therapies, and immunotherapy with CAR T cells has the potential to meet this challenge. However, there is a lack of preclinical models that mimic salient features of human disease including reliable development of metastatic disease post orthotopic OS cell injection. To overcome this roadblock, and also enable real-time imaging of metastatic disease, we took advantage of LM7 OS cells expressing firefly luciferase (LM7.ffLuc). LM7.ffLuc were implanted in a collagen mesh into the tibia of mice, and mice reliably developed orthotopic tumors and lung metastases as judged by bioluminescence imaging and histopathological analysis. Intratibial implantation also enabled surgical remo</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.</pubmed_title><pmcid>PMC8239305</pmcid><funding_grant_id>R25 CA023944</funding_grant_id><funding_grant_id>182154010</funding_grant_id><funding_grant_id>94-000R19</funding_grant_id><funding_grant_id>P01 CA096832</funding_grant_id><funding_grant_id>R50 CA211481</funding_grant_id><pubmed_authors>Ross A</pubmed_authors><pubmed_authors>DeRenzo C</pubmed_authors><pubmed_authors>Tillman H</pubmed_authors><pubmed_authors>Talbot LJ</pubmed_authors><pubmed_authors>Davidoff A</pubmed_authors><pubmed_authors>Chabot A</pubmed_authors><pubmed_authors>Funk A</pubmed_authors><pubmed_authors>Gottschalk S</pubmed_authors><pubmed_authors>Nguyen P</pubmed_authors><pubmed_authors>Wagner J</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.</name><description>The outcome for metastatic pediatric osteosarcoma (OS) remains poor. Thus, there is an urgent need to develop novel therapies, and immunotherapy with CAR T cells has the potential to meet this challenge. However, there is a lack of preclinical models that mimic salient features of human disease including reliable development of metastatic disease post orthotopic OS cell injection. To overcome this roadblock, and also enable real-time imaging of metastatic disease, we took advantage of LM7 OS cells expressing firefly luciferase (LM7.ffLuc). LM7.ffLuc were implanted in a collagen mesh into the tibia of mice, and mice reliably developed orthotopic tumors and lung metastases as judged by bioluminescence imaging and histopathological analysis. Intratibial implantation also enabled surgical remo</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-04T09:11:05.15Z</modification><creation>2022-02-10T17:59:01.194Z</creation></dates><accession>S-EPMC8239305</accession><cross_references><pubmed>34211478</pubmed><doi>10.3389/fimmu.2021.691741</doi></cross_references></HashMap>